4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
US7915232B2 · kind B2 · utility
25Cited by
7References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2009 |
| Grant date | Mar 29, 2011 |
| Priority date | — |
| Expiry date | Sep 14, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of nucleoside derivatives of formula Iawherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof which inhibit HCV polymerase and are useful for treating a patient suffering from a HCV infection and to pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.